The Envigo brand story

At Envigo, we are proud of our customer-centric culture which makes us responsive to every customer, no matter their size, continually optimizing their research programs to ensure consistently clear results. Learn more

Corporate social responsibility

Corporate social responsibility (CSR) has always been part of the way we’ve done business—it's what we do and how we do it. Learn more

Research models

Use our advanced search tool below to find the exact model you need.


Quick Links

Health monitoring reports
Genetic monitoring reports
Cell line references

Envigo proud to take a leading role at ACT's 37th Annual Meeting

Envigo are delighted to announce our attendance and gold sponsorship of the American College of Toxciology's 37th Annual Meeting next month. Read More

Envigo collaboration with OCSiAl and Intertek results in single wall carbon nanotubes completing REACH registration for the first time ever

Envigo is pleased to announce the successful outcome of its industry collaboration with Intertek and OCSiAl. Read More

Envigo invests in Science and Technology Advisory Group (STAG)

STAG will act as an internal funding body for promising research; develop new assays and technologies alongside customers and attract the next generation of scientists. Read More

See All Latest News
Envigo oncology brochure (USA | EU)

At Envigo, we understand that our customers conduct research and develop products that have the potential to offer significant improvements to global health and the environment. We also realize achieving that potential has grown more challenging. That is why we remain focused on your goals, needs and expectations, ensuring you have a trusted partner to advance your life-changing research and products.

Developments in LifeSciences Vol. 15, No. 1

In this issue:
• 20 critical questions for ensuring inhaled crop protection and chemical registration
• The CRO landscape — An evolving safety testing market
• Substance identity: The critical component of both lead and co-registrant dossiers
• The extended one-generation reproductive toxicity study (EOGRTS), OECD test guideline 443

Webinar on-demand
Key considerations in the safety evaluation of drugs targeting immune checkpoints

Presented by Lee Coney (Chief Scientific Officer - Biologics) and Mandy Horn (Supervisor - Veterinary Science, Research and Support). You will learn what is cancer immunotherapy; what are the potential challenges in the safety assessment of antibodies targeting immune system checkpoints?; Things to consider when designing and running your nonclinical safety programmes for immune checkpoint targets; and more.

See all insights